An electronic nose distinguishes exhaled breath of patients with Malignant Pleural Mesothelioma from controls

Grellier, 2008, Mesothelioma asbestos-related pleural diseases, Respiration, 76, 1, 10.1159/000127577 Kazan-Allen, 2005, Asbestos and mesothelioma: worldwide trends, Lung Cancer, 49, S3, 10.1016/j.lungcan.2005.03.002 Kaufman, 2008, Current concepts in malignant pleural mesothelioma, Expert Rev Anticancer Ther, 8, 293, 10.1586/14737140.8.2.293 Kent, 2008, Diagnosis, staging and surgical treatment of Malignant Pleural Mesothelioma, Curr Treat Options Oncol, 9, 158, 10.1007/s11864-008-0070-4 Greillier, 2008, Biomarkers for malignant pleural mesothelioma: current status, Mol Diagn Ther, 12, 375, 10.1007/BF03256303 Pauling, 1971, Quantitative analysis of urine vapour and breath by gas-liquid partition chromatography, Proc Natl Acad Sci USA, 68, 2374, 10.1073/pnas.68.10.2374 Moser, 2005, Mass spectrometric profile of exhaled breath, Field study by PTR-MS, Respir Physiol Neurobiol, 145, 295, 10.1016/j.resp.2004.02.002 de Gennaro, 2010, Chemical characterization of exhaled breath to differentiate between patients with malignant plueral mesothelioma from subjects with similar professional asbestos exposure, Anal Bioanal Chem, 398, 3043, 10.1007/s00216-010-4238-y Friedrich, 2009, Scientists seek to sniff out diseases: electronic “noses” may someday be diagnostic tools, JAMA, 301, 585, 10.1001/jama.2009.90 Röck, 2008, Electronic nose: current status and future trends, Chem Rev, 108, 705, 10.1021/cr068121q Briglin, 2002, Exploitation of spatio-temporal information and geometric optimization of signal/noise performance using arrays of carbon black-polymer composite vapor detectors, Sens Actuators B Chem, 82, 54, 10.1016/S0925-4005(01)00991-1 Di Natale, 2003, Lung cancer identification by the analysis of breath by means of an array of non-selective gas sensors, Biosens Bioelectron, 18, 1209, 10.1016/S0956-5663(03)00086-1 Machado, 2005, Detection of lung cancer by sensor array analysis of exhaled breath, Am J Respir Crit Care Med, 171, 1286, 10.1164/rccm.200409-1184OC Mazzone, 2007, Diagnosis of lung cancer by the analysis of exhaled breath with a colorimetric sensor array, Thorax, 62, 565, 10.1136/thx.2006.072892 Dragonieri, 2009, An electronic nose in the discrimination of patients with lung cancer and COPD, Lung Cancer, 64, 166, 10.1016/j.lungcan.2008.08.008 Peng, 2009, Diagnosing lung cancer in exhaled breath using gold nanoparticles, Nat Nanotechnol, 4, 669, 10.1038/nnano.2009.235 Sobin, 2002 Dragonieri, 2007, An electronic nose in the discrimination of patients with asthma and controls, J Allergy Clin Immunol, 120, 856, 10.1016/j.jaci.2007.05.043 Lewis, 2004, Comparison of mammalian and artificial olfaction based on arrays of carbon black-polymer composite vapor detectors, Acc Chem Res, 37, 663, 10.1021/ar030120m Miller, 2005, Standardisation of spirometry, Eur Respir J, 26, 319, 10.1183/09031936.05.00034805 Geladi, 1989, Principal component analysis of multivatiate images, Chemom Intell Lab Syst, 5, 209, 10.1016/0169-7439(89)80049-8 De Maesschalck, 2000, The Mahalanobis distance, Chemom Intell Lab Syst, 50, 1, 10.1016/S0169-7439(99)00047-7 Bianchi, 1997, Pleural plaques as risk indicators for malignant pleural mesothelioma: a necropsy-based study, Am J Ind Med, 32, 445, 10.1002/(SICI)1097-0274(199711)32:5<445::AID-AJIM3>3.0.CO;2-R Peng, 2010, Detection of lung, breast, colorectal and prostate cancers from exhaled breath using a single array of nanosensors, Br J Cancer, 103, 542, 10.1038/sj.bjc.6605810 Fens, 2009, Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma, Am J Respir Crit Care Med, 180, 1076, 10.1164/rccm.200906-0939OC Montuschi, 2010, Diagnostic performance of an electronic nose, fractional exhaled nitric oxide and lung function testing in asthma, Chest, 137, 790, 10.1378/chest.09-1836 Fend, 2006, Prospects for clinical application of electronic-nose technology to early detection of mycobacterium tuberculosis in culture and sputum, J Clin Microbiol, 44, 2039, 10.1128/JCM.01591-05 Hockestein, 2004, Diagnosis of pneumonia with an electronic nose: correlation of vapor signature with chest computed tomography scan findings, Laryngoscope, 114, 1701, 10.1097/00005537-200410000-00005 Hanson, 2005, Electronic nose prediction of a clinical pneumonia score: biosensors and microbes, Anesthesiology, 102, 63, 10.1097/00000542-200501000-00013 Gordon, 2002, Volatile organic compounds as breath biomarkers for active and passive smoking, Enivron Health Perspect, 110, 689, 10.1289/ehp.02110689 Broadhurst, 2007, Statistical strategies for avoiding false discoveries in metabolomics and related experiments, Metabolomics, 2, 4, 10.1007/s11306-006-0037-z Scherpereel, 2010, Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma, Eur Respir J, 35, 479, 10.1183/09031936.00063109 Phillips, 1999, Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study, Lancet, 353, 1930, 10.1016/S0140-6736(98)07552-7 Phillips, 2003, Detection of lung cancer with volatile markers in the breath, Chest, 123, 2115, 10.1378/chest.123.6.2115 Gordon, 1985, Volatile organic compounds in exhaled air from patients with lung cancer, Clin Chem, 31, 1278, 10.1093/clinchem/31.8.1278 Remmer, 1984, Cytochrome P-450 oxidationof alkanes originating as scission products during lipid peroxidation, Xenobiotica, 14, 207, 10.3109/00498258409151406 Risby, 1999, Clinical application of breath biomarkers of oxidative stress status, Free Radic Biol Med, 27, 1182, 10.1016/S0891-5849(99)00212-9 Baylin, 1998, Alterations in DNA methylation: a fundamental aspect of neoplasia, Adv Cancer Res, 72, 141, 10.1016/S0065-230X(08)60702-2 Knottnerus, 2003, Assessment of the accuracy of diagnostic tests: the cross-sectional study, J Clin Epidemiol, 56, 1118, 10.1016/S0895-4356(03)00206-3 Bossuyt, 2003, The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration, Ann Intern Med, 138, W1, 10.7326/0003-4819-138-1-200301070-00012-w1 Gluud, 2005, Evidence based diagnostics, BMJ, 330, 724, 10.1136/bmj.330.7493.724